placenta cell line derived mesenchymal stem extracellular vesicles (Kimera Labs)

N/A

Report date: 2025/06/11 11:17:34

Base Information

Drug Nameplacenta cell line derived mesenchymal stem extracellular vesicles (Kimera Labs)
Drug Alias Namemesenchymal stem extracellular vesicles (Kimera Labs)placenta derived MSC exosomes (Kimera Labs)placenta derived mesenchymal exosomes (kINERA lABS)
ClassificationBiologics > Exosomes > Stem cell-derived exosomesCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cells modulators
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKimera Labs
China Registration ClassN/A

Develop Information

Active CompaniesKimera Labs
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A